BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1233518)

  • 1. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
    Karobath ME
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Receptor-blockade and receptor-hypersensitivity following neuroleptic treatment (author's transl)].
    Nielsen IM; Christensen AV; Hyttel J
    Arzneimittelforschung; 1976; 26(6):1090-2. PubMed ID: 989383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do antipsychotic drugs work?
    Iversen LL
    Neurosci Res Program Bull; 1975 Aug; 13 Suppl():29-51. PubMed ID: 241033
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors.
    Katzman R; Makman MH; Ahn HS; Mishra RK; Gardner E
    Trans Am Neurol Assoc; 1977; 102():76-9. PubMed ID: 98893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychotropic drugs and adenylate cyclase (author's transl)].
    Honda F
    Tanpakushitsu Kakusan Koso; 1977; 22(6):822-6. PubMed ID: 22102
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 9. Is adenylate cyclase the dopamine receptor?
    Arbuthnott GW; Attree TJ; Eccleston D; Loose RW; Martin MJ
    Med Biol; 1974 Oct; 52(5):350-3. PubMed ID: 4372496
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Effect of psychotropic drugs on uptake, retention and biosynthesis of catecholamines as well as on dopamine receptors in isolated synaptosomes.
    Kuruma I; Okada T; Kondo Y
    Jpn J Pharmacol; 1974; 24(0):s:26. PubMed ID: 4545738
    [No Abstract]   [Full Text] [Related]  

  • 11. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.
    Miller R
    Br J Pharmacol; 1975 Mar; 53(3):457P-458P. PubMed ID: 1137755
    [No Abstract]   [Full Text] [Related]  

  • 13. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
    Matthysse S
    Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinsonism induced by dopaminergic antagonists.
    Hornykiewicz O
    Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
    Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
    Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
    Havemann U
    Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 19. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J; Tassin JP; Thierry AM; Bockaert J
    Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings: Dopamine receptor and antipsychotic effects (author's transl)].
    Karobath M
    Arzneimittelforschung; 1976; 26(6):1029-30. PubMed ID: 9103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.